Registry to evaluate the safety of SUNOSI during pregnancy
Official title: SUNOSI® (Solriamfetol) Pregnancy Registry: An Observational Study on the Safety of Solriamfetol Exposure in Pregnant Women and Their Offspring
Run by Axsome Therapeutics, Inc. · NCT06413420 · Data updated 2026-11-12
This study is trying to see if the medication SUNOSI is safe for pregnant women who have narcolepsy or sleep apnea and how it affects their babies.
Quick facts
| Study type | Observational |
|---|---|
| Sex | Women only |
| Enrollment | 1731 (estimated) |
| Sponsor | Axsome Therapeutics, Inc. Industry-sponsored |
| Locations | 2 sites (Morrisville, North Carolina and 1 other locations) |
| Status | Recruiting |
| Started | July 31, 2019 |
| Main results expected | September 2029 |
| Study ends | September 2029 |
| Registry record updated | October 5, 2026 |
| Trial ID | NCT06413420 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this registry are pregnant women of any age who have narcolepsy or obstructive sleep apnea and have been prescribed solriamfetol or other wake-promoting medications.
✕Probably not a fit
Patients who have experienced pregnancy outcomes prior to their first contact with the registry will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The SUNOSI Pregnancy Registry is a prospective, multi-country observational study aimed at assessing the safety of solriamfetol exposure in pregnant women diagnosed with narcolepsy or obstructive sleep apnea. This registry collects health information from enrolled participants and their healthcare providers regarding their pregnancies and the health of their babies up to one year of age. The data collected is strictly observational, relying on routine medical records to inform treatment decisions regarding solriamfetol during pregnancy.
Why it matters
Potential benefit: If successful, this registry could provide critical safety information that helps pregnant women and their healthcare providers make informed decisions about the use of solriamfetol.
How similar studies have gone: While this registry approach is observational, similar studies evaluating medication safety during pregnancy have shown success in providing valuable data for informed clinical decisions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pregnant women of any age * Diagnosed with narcolepsy or obstructive sleep apnea OR has taken solriamfetol or other wake promoting medications or stimulants during pregnancy or in the relevant exposure window before conception * Resident of the US or Canada * Provides written informed consent to participate in the study * Authorization for her HCP(s) to provide data to the registry Exclusion Criteria: * Occurrence of pregnancy outcome prior to first contact with the registry coordination center (RCC)
Where it's running
-
Evidera, a PPD business unit
Morrisville, North Carolina, United States Recruiting -
PPD, Inc.
Wilmington, North Carolina, United States Recruiting
Study contacts
- Study coordinator: Study Director
- Email: sunosipregnancyregistry@ppd.com
- Phone: 1-877-283-6220
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Multimodal Deep Learning to Predict Sleep Apnea Severity from SpO2 and Ballistocardiography
Researchers are testing a smart-mattress-based method that uses SpO2 and ballistocardiography data to predict sleep apnea severity in adults undergoing overnight sleep study.
-
Nightly wearable monitoring with at-home submental electrical stimulation for sleep apnea
This pilot test checks whether wearing a ring sensor at night and doing a 4-week at-home submental electrical stimulation is feasible for adults with obstructive sleep apnea and looks at changes in sleep metrics.
-
Functional capacity and muscle function in adults with obstructive sleep apnea
This study tests how obstructive sleep apnea affects respiratory and peripheral muscle strength, endurance, and upper‑extremity function compared with healthy adults.
-
Transcutaneous Electrical Stimulation for Obstructive Sleep Apnea
This study tests whether applying gentle electrical stimulation to the throat muscles at night can reduce sleep apnea severity in adults with obstructive sleep apnea.
-
Physical activity habits and sleep/ breathing in obstructive sleep apnea
This study tests whether daily physical activity habits affect sleep quality and breathing measurements in people with obstructive sleep apnea who are on CPAP therapy.
-
CES-EES score and a wearable ring for diagnosing obstructive sleep apnea
This study tests whether the CES-EES clinical score and the Belun Ring wearable can accurately diagnose obstructive sleep apnea without in-lab polysomnography in adults referred for suspected OSA.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.